Almost half of 206 hospital executives polled in a recent survey said they do not intend to use an accountable care organization (ACO)-like model in their health systems. Only 20% of those polled currently participate in an ACO.
Almost half of 206 hospital executives polled in a recent survey said they do not intend to use an accountable care organization (ACO)-like model in their health systems. Only 20% of those polled currently participate in an ACO.
According to the official Purdue Healthcare Advisors report on the survey results, executives are waiting for ACO models that are more stable and mature, in order to avoid having to reinvest funds to implement changes or updates, according to the survey. The executives who do not have plans to implement an ACO model in the future (46%) cited the following reasons:
The findings also identified financial concerns and available resource capabilities for the support of electronic health records as reasons for executives’ reluctance regarding ACO models.
“This survey has identified a significant need for advocacy and education to support hospitals and help them survive the wave of changes brought on by the Affordable Care Act,” said Mary Anne Sloan, director of Purdue Healthcare Advisors, in a public statement. “Hospital executives are charged with enhancing patient care and managing margins with a shrinking workforce and diminishing patient volumes.”
Around the Web
Survey: Hospitals Slow to Adopt Accountable Care, Form ACOs [EHR Intelligence]
Survey reveals hospital executives reluctant to implement ACO models [Purdue Healthcare Advisors]
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen